Introduction Since the onset of the pandemic, prescribing antimicrobials has become a
common practice to treat patients infected with COVID-19. Areas covered A systematic …

This scoping review aimed to explore the prevalence and patterns of global antibiotic use
and bacterial infection in COVID-19 patients from studies published between June 2020 and …

Background Peru is the country with the world's highest COVID-19 death rate per capita.
Characteristics associated with increased mortality among adult patients with COVID-19 …

Since the start of the COVID-19 pandemic, there has been concern about the concomitant
rise of antimicrobial resistance (AMR). While bacterial co-infections seem rare in COVID-19 …

Purpose The coronavirus disease (COVID-19) outbreak has created a global health crisis.
Secondary pulmonary bacterial infection is a COVID-19 complication, increasing morbidity …

Medical care for patients hospitalized with COVID-19 is an evolving process. Most COVID-
19 inpatients (58–95%) received empiric antibiotics to prevent the increased mortality due to …

Antimicrobial resistance (AMR) is a global concern, and antibiotic use has risen throughout
the COVID-19 pandemic. Up to 75% of COVID-19 patients are treated with antibiotics …

Antimicrobial resistance (AMR) poses an immediate danger to global health. If unaddressed,
the current upsurge in AMR threatens to reverse the achievements in reducing the infectious …

This statement addresses the inappropriate antibiotic prescribing occurring during the
coronavirus 2019 pandemic (COVID-19) that has exacerbated another urgent public health …

Background: Since the SARS-CoV-2 pandemic emerged, antimicrobial stewardship (AS)
activities need to be diverted into COVID-19 management. Methods: In order to assess the …